[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Mary M. Mader<\/i><\/u><\/presenter>. Indiana Biosciences Research Institute, Indianapolis, IN","CSlideId":"","ControlKey":"457abf1a-fc00-459d-9908-47d15becc6a5","ControlNumber":"11198","DisclosureBlock":"","End":"4\/7\/2024 1:01:00 PM","HasWebcast":null,"Highlights":[],"Id":"9822","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Mary Mader, PhD","PresenterKey":"89b9ce76-5367-47da-ba66-c08410ee7a55","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Cochairperson","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 1:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Cochairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Benjamin L. Ebert<\/i><\/u><\/presenter>. Dana-Farber Cancer Institute, Boston, MA","CSlideId":"","ControlKey":"e5112b37-dea4-4b7c-be70-be5b335947bf","ControlNumber":"11199","DisclosureBlock":"&nbsp;<b>&nbsp;B.L. Ebert:<\/b>  ; Calico. ; Deerfield. ; Exo Therapeutics. ; Neomorph Therapeutics. ; Novartis. ; Skyhawk Therapeutics. ; TenSixteen Bio.","End":"4\/7\/2024 1:01:00 PM","HasWebcast":null,"Highlights":[],"Id":"9823","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Benjamin Ebert, MD;PhD","PresenterKey":"975fc6b0-d59e-4801-bf10-1fc6ce75de54","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Cochairperson","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 1:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Cochairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Mary M. Mader<\/i><\/u><\/presenter>. Indiana Biosciences Research Institute, Indianapolis, IN","CSlideId":"","ControlKey":"8a812aa5-2575-46ce-9579-75bd027525af","ControlNumber":"11330","DisclosureBlock":"","End":"4\/7\/2024 1:05:00 PM","HasWebcast":null,"Highlights":[],"Id":"9971","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Mary Mader, PhD","PresenterKey":"89b9ce76-5367-47da-ba66-c08410ee7a55","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Introduction","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 1:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Introduction","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":"++IM01-11 Therapeutic antibodies, including engineered antibodies,,"},{"Key":"Keywords","Value":"Natural killer cells,c-Met,NKG2D,multi-specific immune engager therapy,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Jennifer Stone<\/i><\/u><\/presenter>, <presenter><i>Kamonwan Pear Fish<\/i><\/presenter>, <presenter><i>Devika Ashok<\/i><\/presenter>, <presenter><i>Laura McKay<\/i><\/presenter>, <presenter><i>Saeed Akhand<\/i><\/presenter>, <presenter><i>Weilong Zhao<\/i><\/presenter>, <presenter><i>Si Wu<\/i><\/presenter>, <presenter><i>Amani Makkouk<\/i><\/presenter>, <presenter><i>Cormac Cosgrove<\/i><\/presenter>, <presenter><i>Paul Ellis<\/i><\/presenter>, <presenter><i>David Peetz<\/i><\/presenter>, <presenter><i>Stephanie Shee<\/i><\/presenter>, <presenter><i>Richard Peterson II<\/i><\/presenter>, <presenter><i>Shelby Anderson<\/i><\/presenter>, <presenter><i>Adam Chervin<\/i><\/presenter>, <presenter><i>Claudina Stevenson<\/i><\/presenter>, <presenter><i>Tamar Uziel<\/i><\/presenter>, <presenter><i>Edward Reilly<\/i><\/presenter>. Oncology Discovery Research, AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL, Precision Medicine Oncology, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, Genomics Research, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, Global Preclinical Safety Pathology and Histology, AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL, Quantitative, Translational & ADME Sciences, AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL, Oncology Early Development, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, Precision Medicine Oncology, AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL","CSlideId":"","ControlKey":"6b2a4d63-6c78-4b27-bc05-fc0e5cba8d6f","ControlNumber":"11200","DisclosureBlock":"","End":"4\/7\/2024 1:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"9824","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"ND01","PresenterBiography":null,"PresenterDisplayName":"Jennifer Stone, PhD","PresenterKey":"d35c5aed-dba4-4414-8604-792621be3a6f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"ND01. ABBV-303: A novel NK and CD8 T cell engager specific for c-Met-expressing tumors","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 1:05:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"ABBV-303: A novel NK and CD8 T cell engager specific for c-Met-expressing tumors","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"d8f836fd-31c5-4bd1-ad20-080d90b3839c","ControlNumber":"11227","DisclosureBlock":"","End":"4\/7\/2024 1:25:00 PM","HasWebcast":null,"Highlights":[],"Id":"9851","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 1:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":"++ET02-05 New targets,,"},{"Key":"Keywords","Value":"Androgen receptor,BMS-986365,Ligand-directed AR degrader (AR LDD),Prostate cancer,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Shuichan Xu<\/i><\/u><\/presenter>, <presenter><i>Surendra Nayak<\/i><\/presenter>, <presenter><i>John D. Norris<\/i><\/presenter>, <presenter><i>Massimo Ammirante<\/i><\/presenter>, <presenter><i>Emyly Rychak<\/i><\/presenter>, <presenter><i>Suzanne E. Wardell<\/i><\/presenter>, <presenter><i>Toshiya Tsuji<\/i><\/presenter>, <presenter><i>Ken Liu<\/i><\/presenter>, <presenter><i>Joseph Meiring<\/i><\/presenter>, <presenter><i>Joseph R. Piccotti<\/i><\/presenter>, <presenter><i>Deepak Dalvie<\/i><\/presenter>, <presenter><i>Debbie Liao<\/i><\/presenter>, <presenter><i>Raju Kandimalla<\/i><\/presenter>, <presenter><i>Nadia Guerrero<\/i><\/presenter>, <presenter><i>Lisa Sapinoso<\/i><\/presenter>, <presenter><i>Jennifer G. Baker<\/i><\/presenter>, <presenter><i>Yeeun Bae<\/i><\/presenter>, <presenter><i>Joshua Baughman<\/i><\/presenter>, <presenter><i>Brandon Toyama<\/i><\/presenter>, <presenter><i>Celia Fontanillo Fontanillo<\/i><\/presenter>, <presenter><i>Stephen Norris<\/i><\/presenter>, <presenter><i>Evan J. Horn<\/i><\/presenter>, <presenter><i>Veronique Plantevin-Krenitsky<\/i><\/presenter>, <presenter><i>Deborah Mortensen<\/i><\/presenter>, <presenter><i>Brian Cathers<\/i><\/presenter>, <presenter><i>Marie Hong Nguyen<\/i><\/presenter>, <presenter><i>Joshua D. Hensen<\/i><\/presenter>, <presenter><i>Lawrence G. Hamann<\/i><\/presenter>, <presenter><i>Donald P. McDonnell<\/i><\/presenter>, <presenter><i>Rama Krishna Narla<\/i><\/presenter>, <presenter><i>Mark Rolfe<\/i><\/presenter>. Bristol Myers Squibb, San Diego, CA, Duke University School of Medicine, Durham, NC","CSlideId":"","ControlKey":"0df32d8e-d0d8-4996-b233-1b43a1eac63a","ControlNumber":"11439","DisclosureBlock":"","End":"4\/7\/2024 1:40:00 PM","HasWebcast":null,"Highlights":[],"Id":"10095","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"ND02","PresenterBiography":null,"PresenterDisplayName":"Shuichan Xu, PhD","PresenterKey":"cd8f5318-7b48-4b89-82d6-643ed3181ee6","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"ND02. Discovery of BMS-986365, a ligand-directed androgen receptor degrader (AR LDD) with a dual mechanism-of-action and best-in-class potential, for the treatment of advanced prostate cancer","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 1:25:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discovery of BMS-986365, a ligand-directed androgen receptor degrader (AR LDD) with a dual mechanism-of-action and best-in-class potential, for the treatment of advanced prostate cancer","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"a8fc83d3-3759-431f-b419-7c754725565e","ControlNumber":"11228","DisclosureBlock":"","End":"4\/7\/2024 1:45:00 PM","HasWebcast":null,"Highlights":[],"Id":"9852","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 1:40:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":"++CH01-04 Drug design,,"},{"Key":"Keywords","Value":"Ras,RAS-G12D,RMC-9805,Covalent,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>John E. Knox<\/i><\/u><\/presenter>, <presenter><i>G. Leslie Burnett<\/i><\/presenter>, <presenter><i>Caroline Weller<\/i><\/presenter>, <presenter><i>Lingyan Jiang<\/i><\/presenter>, <presenter><i>Dongyu Zhang<\/i><\/presenter>, <presenter><i>Nicole Vita<\/i><\/presenter>, <presenter><i>Abby Marquez<\/i><\/presenter>, <presenter><i>Kyle J. Seamon<\/i><\/presenter>, <presenter><i>Andrea Gould<\/i><\/presenter>, <presenter><i>Marie Menard<\/i><\/presenter>, <presenter><i>Elsa Quintana<\/i><\/presenter>, <presenter><i>Zhe Chen<\/i><\/presenter>, <presenter><i>Zhican Wang<\/i><\/presenter>, <presenter><i>Zhengping Wang<\/i><\/presenter>, <presenter><i>Elena S. Koltun<\/i><\/presenter>, <presenter><i>Malika Singh<\/i><\/presenter>, <presenter><i>Jingjing Jiang<\/i><\/presenter>, <presenter><i>David Wildes<\/i><\/presenter>, <presenter><i>Jacqueline A.M. Smith<\/i><\/presenter>, <presenter><i>Adrian L. Gill<\/i><\/presenter>. Revolution Medicines, Inc., Redwood City, CA","CSlideId":"","ControlKey":"0c1e407f-1bf5-4dc9-94b5-c1a545959a5a","ControlNumber":"11202","DisclosureBlock":"","End":"4\/7\/2024 2:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"9826","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"ND03","PresenterBiography":null,"PresenterDisplayName":"John Knox, PhD","PresenterKey":"414b94d6-cb9e-4cdc-b382-8aefa35aac58","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"ND03. Discovery of RMC-9805, an oral, covalent tri-complex KRASG12D(ON) inhibitor","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 1:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discovery of RMC-9805, an oral, covalent tri-complex KRASG12D(ON) inhibitor","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"a23026b7-60fc-4e8e-8fc3-8c70132367d4","ControlNumber":"11229","DisclosureBlock":"","End":"4\/7\/2024 2:05:00 PM","HasWebcast":null,"Highlights":[],"Id":"9853","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"9","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 2:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":"++ET09-02 Epigenetic targets,,"},{"Key":"Keywords","Value":"Prostate cancer,EZH2,Chemistry,Epigenetics,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><i>Matthew A. Marx<\/i><\/presenter>, <presenter><i>Aaron C. Burns<\/i><\/presenter>, <presenter><i>Nidhi Arora<\/i><\/presenter>, <presenter><i>Thomas P. Bobinski<\/i><\/presenter>, <presenter><i>David M. Briere<\/i><\/presenter>, <presenter><i>Andrew Calinisan<\/i><\/presenter>, <presenter><i>Robin J. Gunn<\/i><\/presenter>, <presenter><i>John M. Ketcham<\/i><\/presenter>, <presenter><i>David Lawson<\/i><\/presenter>, <presenter><i>Matthew Lee<\/i><\/presenter>, <presenter><i>Peter Olson<\/i><\/presenter>, <presenter><i>Christopher R. Smith<\/i><\/presenter>, <presenter><i>Niranjan Sudhakar<\/i><\/presenter>, <presenter><i>James G. Christensen<\/i><\/presenter>, <presenter><i>Chelsea X. Chen<\/i><\/presenter>, <presenter><i>Natalie Yuen<\/i><\/presenter>, <presenter><i>Livia Ulicna<\/i><\/presenter>, <presenter><i>Frank Duong<\/i><\/presenter>, <presenter><i>Christophe Colas<\/i><\/presenter>, <presenter><i>Anjana Ramnath<\/i><\/presenter>, <presenter><i>Ron Xu<\/i><\/presenter>, <presenter><i>Edna Chow Maneval<\/i><\/presenter>, <presenter><i>Pratik S. Multani<\/i><\/presenter>, <presenter><i>Rupal Patel<\/i><\/presenter>, <presenter><i>Archana Kumar<\/i><\/presenter>, <presenter><i>Anneleen Daemen<\/i><\/presenter>, <presenter><i>Anthony Romero<\/i><\/presenter>, <presenter><i>Melissa R. Junttila<\/i><\/presenter>, <presenter><u><i>Lori S. Friedman<\/i><\/u><\/presenter>. Mirati Therapeutics, San Diego, CA, ORIC Pharmaceuticals, South San Francisco, CA","CSlideId":"","ControlKey":"92bd57d9-e6e9-40e6-8353-c9fd6f925fd9","ControlNumber":"11203","DisclosureBlock":"","End":"4\/7\/2024 2:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"9827","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"10","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"ND04","PresenterBiography":null,"PresenterDisplayName":"Lori Friedman, PhD","PresenterKey":"be1429df-78dc-49c6-af11-d646a16b9064","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"ND04. Discovery of ORIC-944, a novel inhibitor of PRC2 with best-in-class properties for the treatment of prostate cancer","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 2:05:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discovery of ORIC-944, a novel inhibitor of PRC2 with best-in-class properties for the treatment of prostate cancer","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"1156d8d7-1d0a-4143-8525-7509f1f1b35e","ControlNumber":"11231","DisclosureBlock":"","End":"4\/7\/2024 2:25:00 PM","HasWebcast":null,"Highlights":[],"Id":"9855","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"11","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 2:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Benjamin L. Ebert<\/i><\/u><\/presenter>. Dana-Farber Cancer Institute, Boston, MA","CSlideId":"","ControlKey":"03dfb27b-a868-4260-a52a-2d73b5327bfb","ControlNumber":"11332","DisclosureBlock":"<b>&nbsp;B. L. Ebert, <\/b> <br><b>Calico<\/b> G. <br><b>Deerfield<\/b> G. <br><b>Exo Therapeutics<\/b> I. <br><b>Neomorph Therapeutics<\/b> I. <br><b>Novartis<\/b> G. <br><b>Skyhawk Therapeutics<\/b> I. <br><b>TenSixteen Bio<\/b> I.","End":"4\/7\/2024 2:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"9973","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"12","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Benjamin Ebert, MD;PhD","PresenterKey":"975fc6b0-d59e-4801-bf10-1fc6ce75de54","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Closing remarks","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:00PM","SessionId":"552","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 1","ShowChatLink":"false","Start":"4\/7\/2024 2:25:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Closing remarks","Topics":null,"cSlideId":""}]